- Home
- CLLS vs ARQQ Comparison
CLLS vs ARQQ Comparison
Compare CLLS & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- ARQQ
- Stock Information
- Founded
- CLLS 1999
- ARQQ 2017
- Country
- CLLS France
- ARQQ United Kingdom
- Employees
- CLLS N/A
- ARQQ N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- ARQQ Computer Software: Prepackaged Software
- Sector
- CLLS Health Care
- ARQQ Technology
- Exchange
- CLLS Nasdaq
- ARQQ Nasdaq
- Market Cap
- CLLS 148.1M
- ARQQ 173.1M
- IPO Year
- CLLS 2007
- ARQQ N/A
- Fundamental
- Price
- CLLS $1.45
- ARQQ $14.95
- Analyst Decision
- CLLS Buy
- ARQQ Strong Buy
- Analyst Count
- CLLS 3
- ARQQ 1
- Target Price
- CLLS $7.00
- ARQQ $52.00
- AVG Volume (30 Days)
- CLLS 120.5K
- ARQQ 285.1K
- Earning Date
- CLLS 05-27-2025
- ARQQ 05-19-2025
- Dividend Yield
- CLLS N/A
- ARQQ N/A
- EPS Growth
- CLLS N/A
- ARQQ N/A
- EPS
- CLLS N/A
- ARQQ N/A
- Revenue
- CLLS $49,217,000.00
- ARQQ $293,000.00
- Revenue This Year
- CLLS $1.26
- ARQQ $1,818.77
- Revenue Next Year
- CLLS N/A
- ARQQ N/A
- P/E Ratio
- CLLS N/A
- ARQQ N/A
- Revenue Growth
- CLLS 435.38
- ARQQ N/A
- 52 Week Low
- CLLS $1.10
- ARQQ $3.72
- 52 Week High
- CLLS $3.38
- ARQQ $52.79
- Technical
- Relative Strength Index (RSI)
- CLLS 60.38
- ARQQ 49.74
- Support Level
- CLLS $1.40
- ARQQ $13.80
- Resistance Level
- CLLS $1.56
- ARQQ $16.00
- Average True Range (ATR)
- CLLS 0.09
- ARQQ 1.48
- MACD
- CLLS 0.03
- ARQQ 0.18
- Stochastic Oscillator
- CLLS 76.09
- ARQQ 79.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.